Paul C Grint's Net Worth

$2.43 Million

Estimate Recalculated Jul 15, 2025 03:16PM EST

Who is Paul C Grint

Paul C Grint has an estimated net worth of $2.43 Million. This is based on reported shares across multiple companies, which include ILLUMINA INC, AmpliPhi Biosciences Corp, Regulus Therapeutics Inc., and Inhibikase Therapeutics, Inc..

SEC CIK

Paul C Grint's CIK is 0001236548

Past Insider Trading and Trends

2010 was Paul C Grint's most active year for acquiring shares with 6 total transactions. Paul C Grint's most active month to acquire stocks was the month of April. 2010 was Paul C Grint's most active year for disposing of shares, totalling 8 transactions. Paul C Grint's most active month to dispose stocks was the month of September. 2010 saw Paul C Grint paying a total of $130,650.00 for 45,300 shares, this is the most they've acquired in one year. In 2010 Paul C Grint cashed out on 60,800 shares for a total of $1,496,373.94, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ILLUMINA INC

Investor
Updated Jan 07, 2013
Form 4
3.66%
295.00
Jan 07, 2013
8.37K
Grant
Jan 03
Form 4
4.44%
343.00
Oct 03, 2012
8.07K
Grant
Oct 01
Form 4
4.50%
333.00
$44.95
$14.97K
Jul 05, 2012
7.73K
Grant
Jul 03
Form 4
205.58%
12.24K
Apr 20, 2012
18.19K
Grant
Apr 18
Form 4
5.57%
314.00
Apr 09, 2012
5.95K
Grant
Apr 05
Form 4
291.43%
12.24K
May 12, 2011
16.44K
Grant
May 10
Form 4
-41.32%
-10.00K
$30.09
-$514.54K
Oct 29, 2010
14.20K
Sale
ScheduledOct 27
Form 4
-29.24%
-10.00K
$25.68
-$426.49K
Oct 29, 2010
24.20K
Sale
ScheduledAug 06
Form 4
-22.62%
-10.00K
$23.92
-$391.18K
Aug 03, 2010
34.20K
Sale
ScheduledJul 30
Form 4
453.13%
14.50K
$41.89
-$33.51K
May 12, 2010
17.70K
Acquisition
May 10 - May 12
Form 4
810.00%
16.20K
$36.43
-$29.14K
May 11, 2009
18.20K
Acquisition
May 07 - May 08
Form 4
8.50K
May 20, 2008
8.50K
Grant
May 16
Form 4
10.00K
Jul 25, 2007
10.00K
Grant
Jun 07
Form 4
8.00K
Jun 09, 2006
8.00K
Grant
Jun 08
Form 4
20.00K
Apr 14, 2005
20.00K
Grant
Apr 12
Form 3
Apr 14, 2005
Showing 16 results

AmpliPhi Biosciences Corp

Chief Executive Officer
Updated Dec 12, 2017
Form 4
599.00
$0.62
$371.38
Dec 12, 2017
599.00
Grant
Dec 08
Form 4
475.19K
Sep 11, 2017
475.19K
Grant
Sep 07
Form 4
16.20K
Nov 09, 2015
16.20K
Grant
Nov 05
Form 3
Nov 09, 2015
Showing 4 results

Regulus Therapeutics Inc.

President & CEO
Updated Feb 23, 2017
Form 4
410.00K
Feb 23, 2017
410.00K
Grant
Feb 15
Form 4
130.00K
Feb 01, 2017
130.00K
Grant
Jan 30
Form 4
186.64K
Oct 07, 2016
186.64K
Grant
Oct 05
Form 4
265.00K
Feb 05, 2016
265.00K
Grant
Feb 04
Form 4
30.00K
Jan 06, 2016
30.00K
Grant
Dec 16
Form 4
500.00K
Jun 26, 2015
500.00K
Grant
Jun 25
Form 4
50.87K
Dec 04, 2014
50.87K
Grant
Dec 02
Form 4
40.00K
Oct 22, 2014
40.00K
Grant
Oct 20
Form 4
250.00K
Jun 18, 2014
250.00K
Grant
Jun 16
Form 3
Jun 18, 2014
Showing 10 results

Inhibikase Therapeutics, Inc.

Investor
Updated Jul 18, 2024
Form 4
30.00K
Jul 18, 2024
30.00K
Grant
Jul 16
Form 4
6.67K
Jul 05, 2023
6.67K
Grant
Jun 30
Form 4
40.00K
Jun 28, 2022
40.00K
Grant
Jun 24
Form 4
22.68K
Jun 29, 2021
22.68K
Grant
Jun 25
Form 4
6.83K
Dec 29, 2020
6.83K
Grant
Dec 22
Form 3
Dec 22, 2020
Showing 6 results